Investor Relations Investor Center Stock Information Financial Information Corporate Governance Press Releases Events & Presentations Investor FAQ Contact Us
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira Receives Notice of Clinical Hold for TKM-Ebola Phase I Clinical Trial Jul 03, 2014 Tekmira Receives Notice of Clinical Hold for TKM-Ebola Phase I Clinical Trial 19.3 KB ... Read more Summary ToggleTekmira Initiating Phase I/II Clinical Trial in Patients with Hepatocellular Carcinoma May 27, 2014 Tekmira Initiating Phase I/II Clinical Trial in Patients with Hepatocellular Carcinoma 21.5 KB ... Read more Summary ToggleTekmira Presents Positive Interim Results on Phase I/II Clinical Programs May 21, 2014 Tekmira Presents Positive Interim Results on Phase I/II Clinical Programs 26.6 KB Confirms Safety Profile of Third Generation LNP ... Read more Summary ToggleTekmira Provides Corporate Update and Announces First Quarter 2014 Results May 14, 2014 Tekmira Provides Corporate Update and Announces First Quarter 2014 Results 26.9 KB Conference Call at 4:30 pm Eastern Time Today ... Read more Summary ToggleTekmira Reports on Voting Results From 2014 Annual Meeting of Shareholders May 09, 2014 Tekmira Reports on Voting Results From 2014 Annual Meeting of Shareholders 12.9 KB ... Read more Summary ToggleTekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results May 07, 2014 Tekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results 12.6 KB ... Read more Summary ToggleTekmira's Partner Presents New Clinical Data for LNP-Enabled Patisiran (ALN-TTR02) Apr 28, 2014 Tekmira's Partner Presents New Clinical Data for LNP-Enabled Patisiran (ALN-TTR02) 20 KB Tekmira's LNP Technology Further Validated With New Results ... Read more Summary ToggleTekmira Presents Advances in Anti-Viral Product Platform at Scientific Symposium Apr 01, 2014 Tekmira Presents Advances in Anti-Viral Product Platform at Scientific Symposium 18.5 KB Preclinical Results Demonstrate Survival Following Lethal Marburg Infection When Treatment is Delayed 72 Hours ... Read more Summary ToggleTekmira Announces Completion of Underwritten Public Offering of Common Stock Mar 18, 2014 Tekmira Announces Completion of Underwritten Public Offering of Common Stock 17.4 KB ... Read more Summary ToggleTekmira Announces Pricing of Underwritten Public Offering of Common Stock Mar 13, 2014 Tekmira Announces Pricing of Underwritten Public Offering of Common Stock 17.5 KB ... Read more Pagination First page First Previous page Previous … Page 30 Current page 31 Page 32 Page 33 … Next page Next Last page Last Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira Receives Notice of Clinical Hold for TKM-Ebola Phase I Clinical Trial Jul 03, 2014 Tekmira Receives Notice of Clinical Hold for TKM-Ebola Phase I Clinical Trial 19.3 KB ... Read more Summary ToggleTekmira Initiating Phase I/II Clinical Trial in Patients with Hepatocellular Carcinoma May 27, 2014 Tekmira Initiating Phase I/II Clinical Trial in Patients with Hepatocellular Carcinoma 21.5 KB ... Read more Summary ToggleTekmira Presents Positive Interim Results on Phase I/II Clinical Programs May 21, 2014 Tekmira Presents Positive Interim Results on Phase I/II Clinical Programs 26.6 KB Confirms Safety Profile of Third Generation LNP ... Read more Summary ToggleTekmira Provides Corporate Update and Announces First Quarter 2014 Results May 14, 2014 Tekmira Provides Corporate Update and Announces First Quarter 2014 Results 26.9 KB Conference Call at 4:30 pm Eastern Time Today ... Read more Summary ToggleTekmira Reports on Voting Results From 2014 Annual Meeting of Shareholders May 09, 2014 Tekmira Reports on Voting Results From 2014 Annual Meeting of Shareholders 12.9 KB ... Read more Summary ToggleTekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results May 07, 2014 Tekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results 12.6 KB ... Read more Summary ToggleTekmira's Partner Presents New Clinical Data for LNP-Enabled Patisiran (ALN-TTR02) Apr 28, 2014 Tekmira's Partner Presents New Clinical Data for LNP-Enabled Patisiran (ALN-TTR02) 20 KB Tekmira's LNP Technology Further Validated With New Results ... Read more Summary ToggleTekmira Presents Advances in Anti-Viral Product Platform at Scientific Symposium Apr 01, 2014 Tekmira Presents Advances in Anti-Viral Product Platform at Scientific Symposium 18.5 KB Preclinical Results Demonstrate Survival Following Lethal Marburg Infection When Treatment is Delayed 72 Hours ... Read more Summary ToggleTekmira Announces Completion of Underwritten Public Offering of Common Stock Mar 18, 2014 Tekmira Announces Completion of Underwritten Public Offering of Common Stock 17.4 KB ... Read more Summary ToggleTekmira Announces Pricing of Underwritten Public Offering of Common Stock Mar 13, 2014 Tekmira Announces Pricing of Underwritten Public Offering of Common Stock 17.5 KB ... Read more Pagination First page First Previous page Previous … Page 30 Current page 31 Page 32 Page 33 … Next page Next Last page Last
Tekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results 12.6 KB
